EA200800205A1 - CALCIUM PEPTIDE COMPONENT - Google Patents

CALCIUM PEPTIDE COMPONENT

Info

Publication number
EA200800205A1
EA200800205A1 EA200800205A EA200800205A EA200800205A1 EA 200800205 A1 EA200800205 A1 EA 200800205A1 EA 200800205 A EA200800205 A EA 200800205A EA 200800205 A EA200800205 A EA 200800205A EA 200800205 A1 EA200800205 A1 EA 200800205A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptide component
calcium
calcium peptide
caseinophosphopeptide
glycomacropeptide
Prior art date
Application number
EA200800205A
Other languages
Russian (ru)
Other versions
EA016259B1 (en
Inventor
Марко Зелль
Дирк Боде
Гюнтер Заватцки
Original Assignee
Хумана Мильхунион Эг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хумана Мильхунион Эг filed Critical Хумана Мильхунион Эг
Publication of EA200800205A1 publication Critical patent/EA200800205A1/en
Publication of EA016259B1 publication Critical patent/EA016259B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

В заявке описан кальций-пептидный компонент, получаемый по меньшей мере из одной кальциевой соли, казеинофосфопептида и гликомакропептида. Тем самым удается использовать присущий молоку принцип, состоящий в связывании больших количеств кальция с белками.The application describes a calcium peptide component obtained from at least one calcium salt, caseinophosphopeptide and glycomacropeptide. Thus, it is possible to use the principle inherent in milk, consisting in the binding of large quantities of calcium to proteins.

EA200800205A 2005-07-19 2006-05-31 Use of calcium-peptide component for weight reduction EA016259B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033630A DE102005033630A1 (en) 2005-07-19 2005-07-19 Calcium-peptide component
PCT/EP2006/005173 WO2007009529A2 (en) 2005-07-19 2006-05-31 Calcium-peptide component

Publications (2)

Publication Number Publication Date
EA200800205A1 true EA200800205A1 (en) 2008-08-29
EA016259B1 EA016259B1 (en) 2012-03-30

Family

ID=37575596

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800205A EA016259B1 (en) 2005-07-19 2006-05-31 Use of calcium-peptide component for weight reduction

Country Status (5)

Country Link
EP (1) EP1903895A2 (en)
DE (1) DE102005033630A1 (en)
EA (1) EA016259B1 (en)
UA (1) UA94716C2 (en)
WO (1) WO2007009529A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DE102006052560B4 (en) * 2006-11-06 2010-01-21 Humana Milchunion Eg Anti-diabetogenic calcium peptide composition
DE102007022694A1 (en) 2007-05-11 2008-11-13 Humana Milchunion Eg Milk fat milk protein composition to improve calcium absorption
CN107320480A (en) 2009-02-24 2017-11-07 里特制药股份有限公司 Probiotic formulations and application method
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
CN103445045A (en) * 2012-05-30 2013-12-18 孔徐生 Food composition having function of promoting calcium absorption and preparation method thereof
CN109805417A (en) * 2019-03-01 2019-05-28 河南九九一生物科技有限公司 A kind of health food that can increase bone density and its processing method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3373544B2 (en) * 1991-12-05 2003-02-04 明治乳業株式会社 Foods and drinks and pharmaceuticals with excellent calcium utilization that have the effect of alleviating dysmenorrhea
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
US7794744B2 (en) * 2000-04-18 2010-09-14 Nestec S.A. Nutritional modules
US6384087B1 (en) * 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
GB0100273D0 (en) * 2001-01-08 2001-02-14 Nestle Sa Nutritional composition for a bone condition
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
JP2003048843A (en) * 2002-07-17 2003-02-21 Meiji Milk Prod Co Ltd Functional food for preventing and/or treating dysmenorrhea

Also Published As

Publication number Publication date
UA94716C2 (en) 2011-06-10
DE102005033630A1 (en) 2007-01-25
EA016259B1 (en) 2012-03-30
WO2007009529A2 (en) 2007-01-25
WO2007009529A3 (en) 2007-06-28
EP1903895A2 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
DE602005008996D1 (en) RADIOFLUORATED PEPTIDES
EA200800205A1 (en) CALCIUM PEPTIDE COMPONENT
EA201001223A1 (en) STABILIZED PROTEIN COMPOSITIONS
ATE428727T1 (en) NEW PEPTIDES BINDING TO THE ERYTHROPOIETIN RECEPTOR
DE602006018856D1 (en) NEW UTILITY COMPOSITIONS
DE602005012555D1 (en) Artificial protein for the absolute quantification of proteins and uses thereof
EA200801621A1 (en) ANTIBODIES DIRECTED ON HER-3 AND THEIR APPLICATION
ATE482281T1 (en) PLASTID TRANSIT PEPTIDES
DE602005021970D1 (en) USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF PAIN BY BONE CANCER, CHEMOTHERAPY AND NUCLEOSIDE-RELATED PAIN
EA201100070A1 (en) RV2386C TUBERCULOSIC PROTEIN, COMPOSITIONS AND THEIR APPLICATIONS
EA201491049A1 (en) ANTI-TRACT FUSE PROTEIN
CY1116269T1 (en) USE OF A LUIN PROTEIN
MX2008000230A (en) Il-6 binding proteins.
IS8308A (en) Amino acids with affinity for the a2o protein
WO2008093058A3 (en) Peptides and their use
ATE492284T1 (en) TREATMENT OF CHRONIC KIDNEY DISEASE WITH LANTHANUM COMPOUNDS
DE602005013650D1 (en) PROTEIN HYDROLYSATE FOR THE TREATMENT OF TIREDNESS
ATE394123T1 (en) LIQUID FORMULATIONS OF THE TUMOR NECROSIS FRACTOR BINDING PROTEIN TBP-1
EA200800109A1 (en) SUPRAVALENT CONNECTIONS
EA200702353A1 (en) PROTEIN HYDROLYZATES, REDUCING BLOOD PRESSURE
EA200701892A1 (en) COMPOSITIONS CONTAINING RELATED WATER AND COMPONENTS CONTAINED IN A WATER SENSOR BASED
DE602004023624D1 (en) ANTIMICROBIAL PEPTIDES
ATE485831T1 (en) TREATMENT OF NEURODEGENERATION
DE602004018794D1 (en) ANTIMICROBIAL PEPTIDES
RU2007100727A (en) CERAMIC MASS

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU